The following was provided by Luca Escoffier, a PhD student at Queen Mary, University of London a Transatlantic Technology Law Forum (TTLF) fellow at Standford writing his dissertation on patenting medical nanotechnology inventions, and currently a visiting fellow at the University of Washington. He is also the author of the Nanomedicine and IP Blog, and watches European developments for us.
COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN
PARLIAMENT, THE COUNCIL AND THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE – REGULATORY ASPECTS OF NANOMATERIALS
In June 2008, the European Commission, in light of the aims and principles contained in the Communication “Nanosciences and nanotechnologies: an action plan for Europe 2005 – 2009,” which asked for a full compliance when using and applying nanosciences and nanotechnologies with all existing and future rules on health, safety, workers’ protection, and environment, adopted a Communication also reflecting the commitment to adapt the current regulation to such current an future uses and applications. The Communication is a document covering nanomaterials currently in production and/or placed on the market. The Communication does not regard naturally occurring or unintentionally produced nanomaterials or nanoparticles. Please see the text of the Communication and accompanying document for more information.
